Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis

The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasi...

Descripción completa

Detalles Bibliográficos

Autores principales:	I. M. Marusenko, N. N. Vezikova, S. N. Kondrichin, N. D. Silvestrov
Formato:	Artigo
Lenguaje:	Russo
Publicado:	IMA PRESS LLC 2019-03-01
Colección:	Научно-практическая ревматология
Materias:	psoriasis psoriatic arthritis methotrexate infliximab abatacept ustekinumab
Acceso en línea:	https://rsp.mediar-press.net/rsp/article/view/2682
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!